Asenapine (Saphris)

Asenapine is a poor medication choice in treatment of schizophrenia. It has very poor (<2%) bioavailability if ingested, and must be taken sublingually. The patient also needs to avoid food or liquids for 10 min after sublingual administration. Finally it also requires BID dosing.